Inhibikase Therapeutics, Inc. (IKT)

Inhibikase Therapeutics Employees

Inhibikase Therapeutics had 35 employees as of December 31, 2025. The number of employees increased by 19 or 118.75% compared to the previous year.

• Employees: 35
• Change (1Y): 19
• Growth (1Y): 118.75%
• Revenue / Employee: n/a
• Profits / Employee: -$1,456,037
• Market Cap: 318.69M

Employees History

Date	Employees	Change (1Y)	Growth (1Y)	Full-Time	Part-Time
Dec 31, 2025	35	19	118.75%	35	0
Dec 31, 2024	16	7	77.78%	15	1
Dec 31, 2023	9	2	28.57%	8	1
Dec 31, 2022	7	0	-	6	1
Dec 31, 2021	7	4	133.33%	6	1

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Employee data is provided by S&P Global Market Intelligence and updates every three months after the filing of each quarterly report.

Update frequency:

Quarterly

Last checked:

Jun 23, 2026

Data Sources Report a data error